E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12 Severity:T95
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16 Temporality:E46 Temporality2:E42
E17	Condition:T17 Name:T18
E19	Condition:T19 Name:T20 Severity:T100
E21	Condition:T21 Name:T22 Temporality:E45
E26	Condition:T26 Name:T27
E28	Condition:T28 Name:T29
E30	Condition:T30 Name:T31
E32	Condition:T32 Name:T33 Temporality:E44
E34	Condition:T34 Name:T35
E36	Condition:T36 Name:T37
E38	Condition:T38 Name:T39
E40	Condition:T40 Name:T41
E41	Age:T45 Eq-Comparison:E43
E42	Eq-Comparison:T50 Operator:T42 Temporal-Unit:T44 Value:T49
E43	Eq-Comparison:T51 Operator:T46 Value:T47 Value2:T48 Temporal-Unit:T43
E44	Eq-Comparison:T52 Temporal-Period:T53
E45	Eq-Comparison:T54 Temporal-Period:T55
E46	Eq-Comparison:T56 Temporal-Period:T57
E2	Or:T58 Arg:T25 Arg2:T23
E4	And:T59 Arg:E41 Arg2:E3
E6	Assertion:T60 Asserted:E32
E8	Condition:T61 Name:T62
E10	Criteria-Count:T63 Min-Value:E12 Criteria:E8 Criteria2:E1 Criteria3:E34 Criteria4:E36
E12	Eq-Comparison:T64 Value:T65
E14	Or:T66 Arg:E26 Arg2:E1
E16	Modifier:T67 Modifies:T2
E18	Condition:T68 Name:T69
E20	Criteria-Count:T70 Min-Value:E22 Criteria:E13 Criteria2:E5 Criteria3:E17 Criteria4:E7
E22	Eq-Comparison:T71 Value:T72
E23	Or:T73 Arg:E5 Arg2:E17
E24	Or:T74 Arg:E17 Arg2:E7
E25	Modifier:T75
E27	Drug:T76 Name:T77
E29	Drug:T78 Name:T79
E31	Or:T80 Arg:E27 Arg2:E29
E33	Condition:T81 Name:T82
E35	Condition:T83 Name:T84 Stage:E37
E37	Eq-Comparison:T85 Unit:T86 Operator:T87 Value:T88 Value2:T89
E39	Condition:T90 Name:T91
E47	Condition:T92 Name:T93
E48	Or:T94 Arg:E47 Arg2:E33
E49	Condition:T96 Name:T97
E50	Or:T98 Arg:E11 Arg2:E49
E51	Modifier:T99 Modifies:T22
E52	Or:T101 Arg:E21 Arg2:E19
E53	Modifier:T102 Modifies:T16
E54	Study:T103
E55	Temporal-Connection:T104 Arg:E42 Arg2:E54
E56	Encounter:T105 Type:T106
E57	Drug:T107
E58	Or:T108 Arg:E38 Arg2:E57
E59	Other:T109 Is-Other:E57
T1	Condition 299 278	pulmonary arterial hypertension
T2	Condition-Name 299 278	pulmonary arterial hypertension
T3	Condition 129 119	pulmonary arterial hypertension
T4	Condition-Name 129 119	pulmonary arterial hypertension
T5	Condition 466 434	mixed connective tissue disease
T6	Condition-Name 466 434	mixed connective tissue disease
T7	Condition 520 487	lupus erythematosus
T8	Condition-Name 520 487	lupus erythematosus
T9	Condition 389 363	connective tissue diseases
T10	Condition-Name 389 363	connective tissue diseases
T11	Condition 780 730	systemic hypertension
T12	Condition-Name 780 730	systemic hypertension
T13	Condition 432 401	limited scleroderma
T14	Condition-Name 432 401	limited scleroderma
T15	Condition 940 882	right heart failure
T16	Condition-Name 940 882	right heart failure
T17	Condition 486 454	overlap syndrome
T18	Condition-Name 486 454	overlap syndrome
T19	Condition 888 832	cardiac disease
T20	Condition-Name 888 832	cardiac disease
T21	Condition 840 786	heart disease
T22	Condition-Name 840 786	heart disease
T23	Life-Stage-And-Gender 54 49	females
T24	Life-Stage-And-Gender 34 30	Adult
T25	Life-Stage-And-Gender 42 37	males
T26	Condition 252 232	IPAH
T27	Condition-Name 252 232	IPAH
T28	Condition 306 284	HPAH
T29	Condition-Name 306 284	HPAH
T30	Condition 135 124	PAH
T31	Condition-Name 135 124	PAH
T32	Condition 184 169	PAH
T33	Condition-Name 184 169	PAH
T34	Condition 325 299	PAH
T35	Condition-Name 325 299	PAH
T36	Condition 536 501	PAH
T37	Condition-Name 536 501	PAH
T38	Condition 1005 941	PAH
T39	Condition-Name 1005 941	PAH
T40	Condition 1042 978	PAH
T41	Condition-Name 1042 978	PAH
T42	Eq-Operator 947 889	within
T43	Eq-Temporal-Unit 78 70	years
T44	Eq-Temporal-Unit 956 897	days
T45	Age 61 55	aged
T46	Eq-Operator 68 61	to
T47	Eq-Value 65 58	18
T48	Eq-Value 72 64	75
T49	Eq-Value 951 892	30
T50	Eq-Comparison 956 897	within 30 days
T51	Eq-Comparison 78 70	18 to 75 years
T52	Eq-Comparison 155 140	current
T53	Eq-Temporal-Period 155 140	current
T54	Eq-Comparison 810 758	History
T55	Eq-Temporal-Period 810 758	History
T56	Eq-Comparison 903 845	History
T57	Eq-Temporal-Period 903 845	History
T58	Or 46 41	and
T59	And 97 87	with
T60	Assertion 180 165	symptomatic
T61	Condition 245 226	Idiopathic
T62	Condition-Name 245 226	Idiopathic
T63	Criteria-Count 219 204	the following
T64	Eq-Comparison 202 187	one
T65	Eq-Value 202 187	one
T66	Or 257 236	or
T67	Modifier 267 246	heritable
T68	Condition 396 369	CTDs
T69	Condition-Name 396 369	CTDs
T70	Criteria-Count 362 336	the following
T71	Eq-Comparison 345 319	one
T72	Eq-Value 345 319	one
T73	Or 469 437	or
T74	Or 491 458	or
T75	Modifier 500 467	systemic
T76	Drug 563 528	anorexigen
T77	Drug-Name 563 528	anorexigen
T78	Drug 582 547	methamphetamine
T79	Drug-Name 582 547	methamphetamine
T80	Or 566 531	or
T81	Condition 657 615	New York Heart Association
T82	Condition-Name 657 615	New York Heart Association
T83	Condition 664 621	NYHA
T84	Condition-Name 664 621	NYHA
T85	Eq-Comparison 691 645	class II-IV
T86	Eq-Unit 683 639	class
T87	Eq-Operator 688 643	-
T88	Eq-Value 686 642	II
T89	Eq-Value 691 645	IV
T90	Condition 619 582	World Health Organization
T91	Condition-Name 619 582	World Health Organization
T92	Condition 625 587	WHO
T93	Condition-Name 625 587	WHO
T94	Or 630 589	/
T95	Severity 758 708	significant
T96	Condition 795 745	hypotension
T97	Condition-Name 795 745	hypotension
T98	Or 783 733	or
T99	Modifier 826 772	left-sided
T100	Severity 872 816	significant
T101	Or 849 793	and/or
T102	Modifier 920 862	decompensated
T103	Study 969 910	screening
T104	Temporal-Connection 959 900	of
T105	Encounter 997 933	hospitalization
T106	Encounter-Type 997 933	hospitalization
T107	Drug 1053 989	medication
T108	Or 1008 944	or
T109	Other 1038 974	additional
A1	Life-Stage-And-Gender-Type T23 female
A2	Life-Stage-And-Gender-Type T24 adult
A3	Life-Stage-And-Gender-Type T25 male
A4	Eq-Operator-Value T42 LTEQ
A5	Eq-Temporal-Unit-Value T43 year
A6	Eq-Temporal-Unit-Value T44 day
A7	Eq-Operator-Value T46 BETWEEN
A8	Eq-Temporal-Period-Value T53 present
A9	Eq-Temporal-Period-Value T55 past
A10	Eq-Temporal-Period-Value T57 past
A11	Assertion-Type-Value E6 possible
A12	Eq-Operator-Value T87 BETWEEN
A13	Severity-Value T95 severe
A14	Severity-Value T100 severe
A15	Temporal-Connection-Type-Value E55 before
A16	Encounter-Type-Value T106 inpatient
R1	Abbrev-Of Arg1:E30 Arg2:E3
R2	Abbrev-Of Arg1:E26 Arg2:E8
R3	Abbrev-Of Arg1:E28 Arg2:E1
R4	Abbrev-Of Arg1:E18 Arg2:E9
R5	Caused-By Arg1:E34 Arg2:E9
R6	Abbrev-Of Arg1:E25 Arg2:E7
R7	Caused-By Arg1:E36 Arg2:E27
R8	Abbrev-Of Arg1:E35 Arg2:E33
R9	Abbrev-Of Arg1:E47 Arg2:E39
R10	Treatment-For Arg1:E56 Arg2:E38
R11	Example-Of Arg1:E56 Arg2:E15
R12	Treatment-For Arg1:E57 Arg2:E40